Results 261 to 270 of about 91,077,287 (299)

Effect of Expanded Hemodialysis with the Theranova Dialyzer on the Platelet-to-Lymphocyte Ratio and Inflammatory Markers. [PDF]

Toxins (Basel)
Jeon YH, Jung HY, Choi JY, Park SH, Kim CD, Kim YL, Lim JH, Cho JH.   +7 more
europepmc   +1 more source

SAKK 35/14 randomized trial of rituximab with or without ibrutinib for patients with untreated follicular lymphoma

British Journal of Haematology, EarlyView.
Summary The randomized phase II SAKK 35/14 trial, conducted by the Swiss Group for Clinical Cancer Research (SAKK) and the Nordic Lymphoma Group (NLG), compared efficacy and safety of rituximab (375 mg/m2 intravenously for 4 weeks followed by maintenance every 2 months for 24 months) plus placebo (arm A) versus the same schedule of rituximab plus ...
Maria Cristina Pirosa, Marianne Brodtkorb, Sämi Schär, Björn E. Wahlin, Micaela Hernberg, Michael Pedersen, Anastasios Stathis, Thilo Zander, Urban Novak, Thorsten Zenz, Natalie Fischer, Fatime Krasniqi, Felicitas Hitz, Ann‐Sofie Johansson, David Löfgren, Peter Albert Meyer, Anne Turid Bjørnevik, Giulio Sartori, Stefanie Hayoz, Andrea Fuhrer, Luzia Steiner, Francesco Bertoni, Luca Ceriani, Stefan Dirnhofer, Emanuele Zucca, Bjørn Østenstad   +25 more
wiley   +1 more source

Neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and systemic immune-inflammation index as predictors of venous thromboembolism in patients with diffuse large B-cell lymphoma. [PDF]

Thromb J
Almalki W, Alenezi A, Almutairi R, Alsadhan A.   +3 more
europepmc   +1 more source

Survival after first relapse in marginal zone lymphomas: Prospective data from the international observational NF10 study

British Journal of Haematology, EarlyView.
Summary While marginal zone lymphoma (MZL) is generally indolent, outcomes following relapse remain poorly defined. This study utilized the indolent Non Follicular 10 (NF10) prospective database to characterize survival and identify prognostic drivers in patients failing initial systemic therapy. The study analysed 122 patients with relapsed MZL.
Stefano Luminari, Maria Elena Nizzoli, Michele Merli, Sara Rattotti, Vittoria Tarantino, Simone Ferrero, Annalisa Talami, Roberta Murru, Marina Deodato, Emanuele Cencini, Giovanni Roti, Carlo Visco, Guilherme Duffles, Michele Spina, Ombretta Annibali, Alessandro Pulsoni, Andrés José María Ferreri, Caterina Stelitano, Elsa Pennese, Emiliano Barbieri, Marzia Varettoni, Gambara Silvia, Marta Coscia, Dario Marino, Tisi Maria Chiara, Maher Nawar, Luigi Marcheselli, Francesco Merli, Luca Arcaini   +28 more
wiley   +1 more source

Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as prognostic factors in patients with colorectal cancer: a retrospective study. [PDF]

Front Med (Lausanne)
El Muhtaseb MS, Ismail LN, Haddad TA, Ghanayem H, Qudah S, Al Aruri DO, Abufaraj M.   +6 more
europepmc   +1 more source

Association of platelet-to-lymphocyte ratio with depression risk: a systematic review and meta-analysis. [PDF]

Front Psychiatry
Zhu M, Li W.
europepmc   +1 more source

COVID-19 Fog Symptoms Are Associated with Brain Metabolism and Platelet-to-Lymphocyte Ratio-A Cross-Sectional Analysis of the COVMENT Trial Baseline Data. [PDF]

J Clin Med
Lubas A, Bryłowska J, Grzywacz A, Włochacz B, Giżewska A, Dziuk M, Klimkiewicz A, Klimkiewicz J.   +7 more
europepmc   +1 more source

Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio as prognostic indicators in <i>Pneumocystis jirovecii</i> pneumonia. [PDF]

Front Med (Lausanne)
Yu F, Ye Y, Shao M.
europepmc   +1 more source

Platelet-to-Lymphocyte Ratio as a Predictor of Atrial Fibrillation in STEMI Patients. [PDF]

Med Sci Monit
Li T, Zhang Q, Gu X, Tao Y, Yin J.
europepmc   +1 more source

Elevated neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in peripheral blood are associated with higher risk of atherosclerotic renal artery stenosis. [PDF]

Front Cardiovasc Med
Lei M, Li Z, Ling H, Wang X, Wu Y, Zhong G, Xu G.   +6 more
europepmc   +1 more source